News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
278,132 Results
Type
Article (14744)
Company Profile (106)
Press Release (263274)
Multimedia
Podcasts (65)
Webinars (13)
Section
Business (88952)
Career Advice (471)
Deals (15543)
Drug Delivery (73)
Drug Development (36935)
Employer Resources (51)
FDA (6820)
Job Trends (6308)
News (152289)
Policy (14271)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (469)
Accelerated approval (13)
Adcomms (8)
Allergies (67)
Alliances (23482)
ALS (56)
Alzheimer's disease (485)
Antibody-drug conjugate (ADC) (99)
Approvals (7017)
Artificial intelligence (206)
Autoimmune disease (39)
Automation (12)
Bankruptcy (150)
Best Places to Work (4426)
BIOSECURE Act (9)
Biosimilars (118)
Biotechnology (40)
Bladder cancer (38)
Brain cancer (30)
Breast cancer (171)
Cancer (1318)
Cardiovascular disease (164)
Career advice (424)
Career pathing (13)
CAR-T (49)
CDC (6)
Cell therapy (150)
Cervical cancer (9)
Clinical research (32236)
Collaboration (726)
Compensation (325)
Complete response letters (33)
COVID-19 (783)
CRISPR (43)
C-suite (433)
Cystic fibrosis (58)
Data (1870)
Denatured (18)
Depression (46)
Diabetes (126)
Diagnostics (1398)
Digital health (9)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (113)
Drug pricing (114)
Drug shortages (12)
Duchenne muscular dystrophy (81)
Earnings (33690)
Editorial (20)
Employer branding (4)
Employer resources (46)
Events (39441)
Executive appointments (531)
FDA (7955)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (439)
Gene editing (70)
Generative AI (18)
Gene therapy (168)
GLP-1 (439)
Government (1425)
Grass and pollen (4)
Guidances (165)
Healthcare (3657)
HIV (11)
Huntington's disease (12)
IgA nephropathy (37)
Immunology and inflammation (68)
Immuno-oncology (14)
Indications (53)
Infectious disease (847)
Inflammatory bowel disease (73)
Inflation Reduction Act (7)
Influenza (24)
Intellectual property (114)
Interviews (64)
IPO (5940)
IRA (33)
Job creations (2076)
Job search strategy (377)
JPM (28)
Kidney cancer (9)
Labor market (29)
Layoffs (206)
Leadership (8)
Legal (3473)
Liver cancer (22)
Longevity (9)
Lung cancer (184)
Lymphoma (123)
Machine learning (13)
Management (18)
Manufacturing (415)
MASH (67)
Medical device (1559)
Medtech (1566)
Mergers & acquisitions (10031)
Metabolic disorders (434)
Multiple sclerosis (46)
NASH (14)
Neurodegenerative disease (82)
Neuropsychiatric disorders (38)
Neuroscience (919)
Neurotech (1)
NextGen: Class of 2026 (1614)
Non-profit (618)
Now hiring (17)
Obesity (227)
Opinion (141)
Ovarian cancer (39)
Pain (109)
Pancreatic cancer (51)
Parkinson's disease (85)
Partnered (11)
Patents (228)
Patient recruitment (119)
Peanut (12)
People (30015)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase 1 (8350)
Phase 2 (13617)
Phase 3 (12286)
Pipeline (1954)
Policy (135)
Postmarket research (1418)
Preclinical (3368)
Press Release (25)
Prostate cancer (84)
Psychedelics (16)
Radiopharmaceuticals (135)
Rare diseases (351)
Real estate (2680)
Recruiting (18)
Regulatory (11090)
Reports (15)
Research institute (593)
Resumes & cover letters (55)
Rett syndrome (5)
RNA editing (6)
RSV (20)
Schizophrenia (83)
Series A (80)
Series B (50)
Service/supplier (2)
Sickle cell disease (46)
Special edition (10)
Spinal muscular atrophy (81)
Sponsored (10)
Startups (1654)
State (2)
Stomach cancer (5)
Supply chain (50)
Tariffs (68)
The Weekly (45)
Vaccines (232)
Venture capital (33)
Weight loss (140)
Women's health (27)
Worklife (4)
Date
Today (3)
Last 7 days (178)
Last 30 days (672)
Last 365 days (10590)
2026 (975)
2025 (10880)
2024 (12683)
2023 (14430)
2022 (19789)
2021 (20338)
2020 (19250)
2019 (15138)
2018 (11899)
2017 (14115)
2016 (13376)
2015 (15750)
2014 (12637)
2013 (10791)
2012 (11621)
2011 (12147)
2010 (11117)
Location
Africa (318)
Alabama (19)
Alaska (1)
Arizona (82)
Arkansas (3)
Asia (20969)
Australia (2701)
California (3258)
Canada (1495)
China (551)
Colorado (151)
Connecticut (153)
Delaware (123)
Europe (41492)
Florida (604)
Georgia (65)
Hawaii (1)
Idaho (10)
Illinois (361)
India (44)
Indiana (240)
Iowa (2)
Japan (249)
Kansas (78)
Kentucky (20)
Louisiana (4)
Maine (7)
Maryland (428)
Massachusetts (2613)
Michigan (47)
Minnesota (167)
Mississippi (1)
Missouri (36)
Montana (8)
Nebraska (7)
Nevada (21)
New Hampshire (9)
New Jersey (1404)
New Mexico (7)
New York (913)
North Carolina (620)
North Dakota (2)
Northern California (1476)
Ohio (81)
Oklahoma (5)
Oregon (18)
Pennsylvania (740)
Puerto Rico (12)
Rhode Island (17)
South America (512)
South Carolina (19)
Southern California (1430)
Tennessee (53)
Texas (462)
United States (12911)
Utah (62)
Virginia (160)
Washington D.C. (42)
Washington State (224)
West Virginia (1)
Wisconsin (37)
Wyoming (1)
278,132 Results for "rhythm pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rhythm Pharmaceuticals Announces Participation in Upcoming Guggenheim Biotech Summit
February 5, 2026
·
7 min read
Press Releases
Rhythm Pharmaceuticals Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Product Revenues and Upcoming Milestones
January 9, 2026
·
11 min read
Regulatory
FDA Action Alert: GSK, Aldeyra, Rhythm and More
Coming up in the back half of December, the FDA will issue a verdict on Vanda Pharmaceuticals’ gastroparesis drug tradipitant, which it rejected last September, triggering a very public dispute with the company.
December 15, 2025
·
5 min read
·
Tristan Manalac
Press Releases
Rhythm Pharmaceuticals Announces Presentation of Four Datasets at ObesityWeek® 2025
November 10, 2025
·
9 min read
Press Releases
Rhythm Pharmaceuticals to Announce Preliminary Data from Exploratory Phase 2 Trial Evaluating Setmelanotide in Prader-Willi Syndrome
December 11, 2025
·
7 min read
Press Releases
Rhythm Pharmaceuticals Reports Third Quarter 2025 Financial Results and Business Update
November 5, 2025
·
23 min read
Press Releases
Rhythm Pharmaceuticals Announces Preliminary Data from Exploratory Phase 2 Trial that showed Setmelanotide Demonstrated Positive Efficacy Signal in Prader-Willi Syndrome
December 11, 2025
·
11 min read
Press Releases
Rhythm Pharmaceuticals Announces FDA Extension of Review Period for IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity
November 10, 2025
·
8 min read
Press Releases
Rhythm Pharmaceuticals to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
October 21, 2025
·
7 min read
Press Releases
Abbott receives CE Mark for the TactiFlex™ Duo Ablation Catheter to treat patients with abnormal heart rhythms
January 21, 2026
·
5 min read
1 of 27,814
Next
